Mechanical valves used for aortic valve replacement (AVR) continue to be associated with
bleeding risks because of anticoagulation therapy, while bioprosthetic valves are at risk of …

Objective Despite an increasing interest in pediatric aortic valve repair, aortic valve
replacement in children may be unavoidable. The evidence on outcome after pediatric aortic …

Background In patients undergoing aortic-valve or mitral-valve replacement, either a
mechanical or biologic prosthesis is used. Biologic prostheses have been increasingly …

Background The Carpentier-Edwards Perimount pericardial bioprosthesis (Edwards
Lifesciences, Irvine, CA) has demonstrated good long-term outcomes, but its durability …

Aims The objective was to investigate the long-term all-cause mortality in patients aged 50–
69 years after aortic valve replacement (AVR) with bioprosthetic or mechanical valves …

With an aging population, improvement in life expectancy, and significant increase in the
use of bioprosthetic valves, structural valve deterioration will become more and more …

Aims To support decision-making regarding prosthetic valve selection in non-elderly adults,
we aim to provide a detailed overview of outcome after contemporary mechanical aortic …

When bioprosthetic cardiac valves fail, reoperative valve replacement carries a higher risk of
morbidity and mortality compared with initial valve replacement. Transcatheter heart valve …

Patients with severe symptomatic aortic stenosis have a poor prognosis with medical
management alone, and balloon aortic valvuloplasty has failed to provide durable clinical …

OBJECTIVE: Aortic valve replacement using a tissue valve is controversial for patients
younger than 60 years old. The long-term survival in this age group, the expected event …